Genetic System Restored Movement in Spinal Cord Injury
A new method successfully converted local cells into functional neurons, improving motor function in animal models.
Updated on Sept. 29, 2026 in Stroke
Live Poll
Are you optimistic that research into cell reprogramming will lead to effective paralysis treatments?
Researchers have developed a genetic system known as TRANsCre-DIONE that converts reactive astrocytes into new neurons after spinal cord injury. The process was tested in mice and rats, resulting in significant motor recovery compared to untreated controls.
Why it matters
This approach aims to repair damaged tissue by reprogramming existing cells at an injury site, potentially bypassing the complex challenges associated with transplanting external donor cells for spinal recovery.
In a preclinical study, 87% of labelled cells in treated mice expressed neuronal markers eight weeks after injury. While these results show promise in animal motor performance, the findings are preliminary and have not been tested for human application.
The players
TRANsCre-DIONE
A novel genetic system designed to reprogram reactive astrocytes into functional neurons at the site of spinal cord injuries.
The details
The TRANsCre-DIONE system functions by identifying reactive astrocytes near the injury site using specific genetic signals, including GFAP and Lcn2. Once identified, the system forces the expression of the Neurog2 gene, which effectively reprograms these astrocytes into functional neurons. By stimulating this transformation directly within the spinal cord, the researchers enabled the development of motor neurons that helped restore movement in the animal models.
Timeline
8 weeks after injury, treated mice achieved an average motor score of 3.88.
Health Landscape
This research contributes to the broader field of regenerative medicine focused on reversing neurological damage from spinal cord injuries. It marks a significant departure from traditional transplant-based therapies by leveraging the body's own existing cells for repair.
This research is currently in the preclinical stage and does not represent a change to existing medical treatments for spinal cord injuries. Patients should continue to work with their physicians on established rehabilitation protocols as future human trials are explored.
The takeaway
Reprogramming cells directly at an injury site could eventually offer a new way to restore mobility. At this time, it is vital to track progress on long-term safety studies and clinical feasibility for human application through your neurologist.
Further reading
For context on how clinicians approach central nervous system recovery, read more in our Stroke section.
Source note: This article includes information reported by Medindia.
Live Poll
Are you optimistic that research into cell reprogramming will lead to effective paralysis treatments?
